Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-112511
Filing Date
2025-11-14
Accepted
2025-11-14 16:09:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10870
2 EXHIBIT 1 tm2529216d4_ex1.htm EX-24.1 6188
3 EXHIBIT 2 tm2529216d4_ex2.htm EX-24.2 6196
4 EXHIBIT 3 tm2529216d4_ex3.htm EX-99.1 5407
  Complete submission text file 0001104659-25-112511.txt   30691
Mailing Address TWO MANHATTAN WEST 375 NINTH AVENUE, 52ND FLOOR NEW YORK NY 10001
Business Address TWO MANHATTAN WEST 375 NINTH AVENUE, 52ND FLOOR NEW YORK NY 10001 212-478-0000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Subject) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90647 | Film No.: 251486086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)